This observation was less pronounced in CD62L−/− mice with a lower NAFLD activity score (NAS) in CD62L−/− animals (Figure 2E, Figure S5), fewer hepatocyte ballooning, and just the beginning of fine fat droplet formation (Figure 2F). Here, SELL is linked to metabolic dysfunction-associated steatotic liver disease.